XF
XML Financial’s Catalyst Pharmaceutical CPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $217K | Hold |
10,000
| – | – | 0.02% | 344 |
|
2025
Q1 | $243K | Sell |
10,000
-20,000
| -67% | -$485K | 0.02% | 312 |
|
2024
Q4 | $626K | Hold |
30,000
| – | – | 0.06% | 203 |
|
2024
Q3 | $596K | Hold |
30,000
| – | – | 0.06% | 213 |
|
2024
Q2 | $465K | Hold |
30,000
| – | – | 0.05% | 225 |
|
2024
Q1 | $478K | Hold |
30,000
| – | – | 0.05% | 228 |
|
2023
Q4 | $504K | Hold |
30,000
| – | – | 0.05% | 213 |
|
2023
Q3 | $351K | Hold |
30,000
| – | – | 0.04% | 238 |
|
2023
Q2 | $403K | Hold |
30,000
| – | – | 0.05% | 242 |
|
2023
Q1 | $497K | Hold |
30,000
| – | – | 0.06% | 205 |
|
2022
Q4 | $558K | Hold |
30,000
| – | – | 0.07% | 199 |
|
2022
Q3 | $385K | Hold |
30,000
| – | – | 0.05% | 216 |
|
2022
Q2 | $210K | Hold |
30,000
| – | – | 0.05% | 211 |
|
2022
Q1 | $249K | Sell |
30,000
-10,000
| -25% | -$83K | 0.03% | 285 |
|
2021
Q4 | $271K | Hold |
40,000
| – | – | 0.03% | 270 |
|
2021
Q3 | $212K | Hold |
40,000
| – | – | 0.03% | 287 |
|
2021
Q2 | $230K | Hold |
40,000
| – | – | 0.05% | 203 |
|
2021
Q1 | $184K | Hold |
40,000
| – | – | 0.04% | 203 |
|
2020
Q4 | $134K | Hold |
40,000
| – | – | 0.03% | 207 |
|
2020
Q3 | $119K | Hold |
40,000
| – | – | 0.04% | 191 |
|
2020
Q2 | $185K | Buy |
+40,000
| New | +$185K | 0.06% | 181 |
|